Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study reveals potential for more efficient stem cell transplants

16.08.2004


Indiana University School of Medicine study published in Science

Blood-making stem cells found in bone marrow, umbilical cord blood and some adult blood products have been used in transplants to treat cancers, leukemia and immune system disorders and to restore blood cell production compromised by chemotherapy and irradiation. But insufficient numbers of donor cells sometime limit success, especially with cord blood transplants.

An Indiana University School of Medicine study suggests these stem cells can be enhanced in trafficking to the bone marrow and may increase transplant success, particularly in adults. The study, "Modulation of Hematopoietic Stem Cell Homing and Engraftment by CD26," appears in the Aug. 13 issue of Science.



Hematopoietic stem cells, rich sources found in the umbilical cord and placenta, are precursors of mature blood cells. They have the ability to replace damaged or diseased bone marrow systems and can continue to produce mature blood cells. Bone marrow is found in soft fatty tissue inside bones, where red blood cells, white blood cells and platelets are produced and developed.

"The efficiency of hematopoietic stem cell transplantation is important when donor-cell numbers are limiting," says study co-author Hal E. Broxmeyer, Ph.D., Distinguished Professor and chair of the School’s Department of Microbiology and Immunology. "Attempts at growing hematopoietic stem cells outside the body for clinical transplantation have not been encouraging."

Using a mouse model, the study sought an alternative means to enhance the engraftment of stem cells by increasing their homing capability to the bone marrow. IU researchers focused on CD26, an enzyme on the surface of stem cells. They inhibited or deleted the CD protein on donor cells and were able to boost short-term homing, long-term engraftment and hematopoietic stem cell repopulation.

"The results were revealing," says Dr. Broxmeyer. "By inhibiting or deleting CD26, it was possible to increase greatly the efficiency of transplantation. This indicates that improvement of stem cell transplants may be possble in the clinic."

The IU research team also included principal author Kent W. Christopherson, Ph.D., Giao Hangoc, D.V.M., and Charlie Mantel. All are affiliated with the Walther Oncology Center, which Dr. Broxmeyer directs.

Dr. Broxmeyer’s laboratory research, which led to the use of umbilical cord blood for stem cell transplantation to treat a large number of malignant and non-malignant diseases, is internationally recognized.

He was a member of the team that successfully performed the first cord blood transplant in 1988 in France for a young boy suffering from Fanconi anemia, a pre-leukemic and often fatal disease. Dr. Broxmeyer’s laboratory set up the world’s first cord blood bank, which processed the blood for the first five cord blood transplants.

Joe Stuteville | EurekAlert!
Further information:
http://www.iupui.edu

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New Method of Characterizing Graphene

Scientists have developed a new method of characterizing graphene’s properties without applying disruptive electrical contacts, allowing them to investigate both the resistance and quantum capacitance of graphene and other two-dimensional materials. Researchers from the Swiss Nanoscience Institute and the University of Basel’s Department of Physics reported their findings in the journal Physical Review Applied.

Graphene consists of a single layer of carbon atoms. It is transparent, harder than diamond and stronger than steel, yet flexible, and a significantly better...

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

3D printer inks from the woods

30.05.2017 | Life Sciences

How circadian clocks communicate with each other

30.05.2017 | Life Sciences

Graphene and quantum dots put in motion a CMOS-integrated camera that can see the invisible

30.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>